MedPath

Pregnancy Outcomes and Medical Costs According to Gestational Diabetes Mellitus Diagnostic Criteria

Not Applicable
Conditions
Gestational Diabetes
Interventions
Diagnostic Test: IADPSG Criteria
Diagnostic Test: NDDG Criteria
Registration Number
NCT03421262
Lead Sponsor
Hospital Mutua de Terrassa
Brief Summary

The aim of the study is to evaluate differences in pregnancy outcomes and medical costs depending on gestational diabetes diagnostic criteria used (one vs two-step approach).

Detailed Description

Due to Hyperglycemia and Adverse Pregnancy Outcomes study results, a new gestational diabetes mellitus (GDM) diagnostic criteria was defined using a one-step approach (75-g oral glucose tolerance test -OGTT-).

However, not all scientific societies have accepted and have implanted this new diagnostic criteria. The lowest glycemia cut-off of this criteria regarding the two-step approach entails an increase in GDM incidence with discordant studies about its cost-effectivity.

It will be assessed if pregnancy outcomes and medical costs are different depending on diagnostic criteria used.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
3644
Inclusion Criteria
  • Age 18-50 years
  • No expectation that subject will be moving out of the area of the clinical center during the next year
  • Informed Consent Form signed by the subject
Exclusion Criteria
  • Preexisting type 1 or 2 diabetes
  • Advanced HIV( on medications that cause hyperglycemia), severe liver disease, gastric bypass surgery or other illness/surgeries that preclude them from drinking the glucose solution.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
One-step:IADPSG CriteriaIADPSG CriteriaGestational diabetes screening with fasting 2 hour 75g. Receive a fasting 2 hour 75 gr oral glucose tolerance test and diagnosed based on the IADPSG which is if one or more values exceed the following diagnostic threshold: Fasting 92, 1-hour 180, or 2-hour 153 mg/dL.
Two-step:NDDG CriteriaNDDG CriteriaStep 1: Perform a 1h 50-g glucose load test (nonfasting. If the plasma glucose level measured 1 h after the load is 140 mg/dL, proceed to a 100-g OGTT. Step 2: 100-g OGTT. The diagnosis of GDM is made if at least two of the following four plasma glucose levels(measured fasting and 1 h, 2 h, 3 h after the OGTT) are met or exceeded: 105mg/dl, 190mg/dl, 165mg/dl and 145mg/dl respectively
Primary Outcome Measures
NameTimeMethod
Large for gestational ageAt birth of infant

Infant birthweight \>90th centile using customized growth curves

Secondary Outcome Measures
NameTimeMethod
MacrosomiaAt birth of infant

infant birthweight \>=4kg

Small for gestational ageAt birth of infant

infant birthweight \<10th centile using customized growth curves

Hypertension in pregnantFirst 3 months postpartum

classification according to American College of Obstetricians and Gynecologists (Task Force on Hypertension in Pregnancy).

Neonatal obstetric traumaAt birth of infant

rate of shoulder dystocia, clavicle fracture, brachial plexus injury and intrapartum asphyxia

Congenital anomaliesAt birth of infant

Coding of EUROCAT

Neonatal hypoglycemiaup to 4 weeks after delivery

neonatal plasma glucose levels of \<2.5 mmol/L in the first 24 hours of life and \<2.8 mmol/L thereafter.

Neonatal hypocalcemiaup to 4 weeks after delivery

neonatal calcium levels of \<7mg/dl

Neonatal hyperbilirubinemiaup to 4 weeks after delivery

hyperbilirubinemia treated with phototherapy

Neonatal polycythemiaup to 4 weeks after delivery

hematocrit from a peripheral venous sample is \>65 percent

Respiratory Distress Syndromeup to 4 weeks after delivery

onset of progressive respiratory failure shortly after birth, in conjunction with a characteristic chest radiograph (after ruling out other causes).

Infant Outcomesup to 4 weeks after delivery

Pregnancy loss (Miscarriage, stillbirth, neonatal death)

Hypertrophic cardiomyopathyup to 4 weeks after delivery

increased left ventricular (LV) wall thickness ≥15 mm is imaged anywhere in the LV wall (by transthoracic echocardiography)

PolyhydramniosAt birth of infant

Amniotic fluid index ≥25 cm

Gestational age at deliveryAt birth of infant

Gestational age was defined as completed weeks based on last menstrual period or the earliest ultrasound assessment if discordant.

Cesarean sectionAt birth of infant

delivery of a baby through a surgical incision in the mother's abdomen and uterus

Perinatal mortalityFirst 7days postpartum

infant deaths that occur at less than 7 days of age and fetal deaths with a gestational age of 28 weeks or more.

NICU admissionup to 4 weeks after delivery

NICU admission for treatment or surveillance

Maternal hospital stayup to 4 weeks from maternal discharge

Length of hospital stay (days)

Neonatal hospital stayup to 4 weeks from neonatal discharge

Length of hospital stay (days)

Evaluation of mediterranean diet adherenceup to 12-14weeks from last menstrual period.

using Mediterranean Diet Adherence Screener (MEDAS) questionnaire. Score betwwen 0-14; high score indicate maximum mediterranean diet adherence.

Evaluation of health-related physical activityup to 12-14weeks from last menstrual period.

using International Physical Activity Questionnaire (IPAQ). Data collected with IPAQ can be used as a continuous measure (Metabolic Equivalent of Task \[MET\]-minutes/week) or caterorical measure (low, moderate or high physical activity)

Medical costFirst 3 months postpartum

Economic cost include: laboratory costs; glucose bottles (50 g, 100 g and 75 g); pharmaceutical expenditure (exact insulin doses consumed, total pens, needles, strips); medical visits during pregnany and postpartum (endocrinologist,educational nurses, obstetrician and midwifes); total number of tests (ultrasonds, cardiotocography record); cost of intensive care unit admissions (Length of stay and complexity) and total hospital admission costs.

All these variables will be expressed as cost (€).

Trial Locations

Locations (1)

Hospital Universitari Mutua Terrassa

🇪🇸

Terrassa, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath